{"id":823958,"date":"2025-03-11T03:04:10","date_gmt":"2025-03-11T07:04:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"},"modified":"2025-03-11T03:04:10","modified_gmt":"2025-03-11T07:04:10","slug":"belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","title":{"rendered":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, March  11, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zfMD1h_91WFkN3ZZvuAQ_E1neCZCgSApi7pSAAraJaBOwXkKVtnBvvQUwFEuaLxodTt8snZvZz0W-iEZBoTXkg==\" rel=\"nofollow\" target=\"_blank\">Belite Bio<\/a>, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, March 17, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the fourth quarter and full year ended December 31, 2024.<\/p>\n<p align=\"justify\">\n        <strong>Webcast Information<\/strong><br \/>\n        <br \/>\n        <strong>Date: <\/strong>Monday, March 17, 2025<br \/><strong>Time: <\/strong>4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w9OVGZ-UD1ouVNhvnhl5jv3Y0jyU0oqyBEtB3gy7Ahs0Cjd0STd_abxgHTsx1uD2j_MJThPF_f1KBGO-lhaOkcogjOrrGOr4zN3Qijfbiu4IGmseVwcQnByqRZTOE974T7nY7_u6n50ITEhHzHB9RV9kfAdzVZSRLaPDk9tchNI=\" rel=\"nofollow\" target=\"_blank\">https:\/\/events.q4inc.com\/attendee\/481614529<\/a><\/p>\n<p align=\"justify\">\n        <strong>Webcast Link Instructions<\/strong><br \/>\n        <br \/>You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w9OVGZ-UD1ouVNhvnhl5jsMlFlWFm_VH7lJ8u0eD1Cw_xoF5DhzQy5xe6QbVoPQ8ZcEIdL6xVJCcxmhIZ4T5os_igojHAMg9J6xQZ6fWpZNB7Acolj0Bq195g_mvh0-G1UxJj0YWkoJ1XhVn_Qi38WxUpr5edlD-cfSlPRzWHbHpIKRwU5iW_Zliz3xsYtBASuR85T_EN76_FK-4F8nrNx7NFlcRPPSvABsfYyUhTwequiFrWe8QD3zuL5WKg-xcvmSUfuPHYagfbKMF24MsjbmWudlCqHS_ZSYQ_RUxT80Eb-WLt_Xqr_5nW2T6sTavr67ThI0c2bu_wdIt49fWSKevbm5USZGUv46QbuiBJAI3bP-PzMdvajsxttiJPHY_0Ko45EgnaHusTscJrDnAOxVwG0HD4nFZn-kwSlsuYx7g0b1v6QeRXQ_irCFvSabD\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.belitebio.com\/presentations-events\/events<\/a>. A replay will be available for approximately 90 days after the event.<\/p>\n<p>\n        <strong>About Belite Bio<\/strong><br \/>\n        <br \/>Belite Bio is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, such as Stargardt disease type 1 (STGD1) and Geographic Atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite\u2019s lead candidate, Tinlarebant, an oral therapy intended to reduce the accumulation of toxins in the eye, is currently being evaluated in a Phase 3 study (DRAGON) and a Phase 2\/3 study (DRAGON II) in adolescent STGD1 subjects and a Phase 3 study (PHOENIX) in subjects with GA. For more information, follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cBZcs4I7zwQ9kxl8EVk8DeKCfjyJc7k0DgHHqVnvzX4rRshYOSYvP8jysCHwJ8j1319UdCJLfA_WilfNh5QfWgSbFjHtQWFQP8aHbfA86zddT8w434eJ5NgyG7CFI_prA8NNq6l9aAdHvkWiPZLAZVHZW9KUF3w7fBQ3Navx5J0fz-aPD8bsi2sOxJBc6IbOfBwlmj-Broo_AudJo2OwDTxFOMoWmzDD2r3iSHoIXQI7qov6m1LTASKivCcvWKQi8ptvOS8uTt4Jo_0FUAriBvYIb7o9_iFT2PAA7z4DBK5vspcN5k9HdKGIcrEwrLew_czk-Ix1N7XM4N-u7u4OQfveDQRnFrtSzqUvbuWh-BPLG-e7dep_ipEo6U-voRZDY0APhIhvhtLjbEHG7AGcLNoWdvEpfhxE3RaAqZC5CLY=\" rel=\"nofollow\" target=\"_blank\">Twitter<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wMEXxGIh8wAwhH1Fy5OP-Q7yUPuUwXoYrmrU4EiK8ARr5tehSSS3p2XNY57Nq9AZ91dvyrxucdIBVOWd9zfO-cP8y_Lp5gCgf_U50cA_3JfQ7jF-TpJwXPhL12ONmbYc8Okeb5A1dzkzU7RGqLOKrvPQCJc7x2HIzf6uMgkOQ8hBgvgN9iVHYyY_hlbb3BBSCwxBf6BY9mhCN51F5Rj26_HqmP-hV3H-NY-FmET4d3sKF5yHPamiEl76zyzDE8rMXQt0_WNyf4MGiNRT9tXrFPrir7IuBqZfTW4VFbz98AhzowTZ0X6-3plTxyTCRJ_M2rs6jOWHiqgvxWaJ-cv0tA1BH96H0CVy25uYmgSh4H8OViv7ugCVL1MG6neXvxYhFWRv-GKPl-QQ2vx-KZo2BJn-M_793uDJeFcL_coVUOLXhIr_mmnzyWlKglPiXEaz\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aCtHzv-O8y_yOCGwkx4ZOK1YPmhX7FNId_icLZW6Az_6KE4mbcFNXWXwLyIacohqkvJhdhD76O-HYgRpH33YatgUhqFCwxBXMVx1l-ytmaNL8-u8MlKJIUrEuy9DQXeujK4OmlcRp39mReN284_9mU0tmMzhYLtFMKECTgwhkyFkZIH6ByKDHbhywB4ImF_b3_1RYvNN11Ei8sfX6jgW0jqYpN76MBTrqQfpPiUMONsKPFdXq0NHFVhOgzUR-qmfUf42g4ldgLNDGcb6MMdz5M0ebn83oKpp9pwsDzpwkWjFTLoue9J1oW3ednI2iQlSRtq9oGmC3WIxq1xWM-1qOK2E9mMsLuuXtx7CiCRvJGVeahVek-6W00QNqH1TpBahiGm9c9PqMLSo6m-OoJC_bfLyOhbX2pu1aO-ZY0fjvCVV5LLLDxQro8_dlBUcI4Gx\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=otldO8y0T0UpKIgVPUUXBc_UhuCZ9LCLRM6sLMLDyCP083zgIqb3bTD4VwtIQ2MY8mhPCT6LF6yU5m2ChHb2vNs3SWtOszNq8w7tWNQyOeWo_ziZZDE49GEu0b1aQdHspeDmkPLJWZG6GeV4zw8aHLDVGMIiYEIVpSpE8hEjMnZHCkj-TAy-tljckqsbpk_t5eMpIdVxYkf87isMYx3ZVrt6qiM5WLxYg897NK3JBUCiSIJZULEKPsWfhHD5hM0ZxbU2LNDvpLn4JfLMcb_HUx9XK7GWzxuNergCxI6Wp84qONwSaPChvmF2JIlBS_egFEX4GdvmKyDgB7VpOY_HMf_V6wYGjo0KHYHXYYUdACZ3kBn5MYe9GZgDgaKwXtkM0NiRw8s5nspAVFABVpqf8pgAbNnryb810mllbcoQKgJHmhBdlTiG3-dUR_to7am7GNIMKkl2v2xDTGS8J41Z2rwa60pzMEfx6KTKl-ohoNM=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>\u00a0or visit us at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dDJLsh5PGCP9e-kpaSzSg7DAlpy4W45m9hTQwqwuWf93i2dBZBy88NnhmGhlkdDwVvckp7Il9i6A21nOtAIeEozUg5D_HnlRwqjuNMQ7kWdL96pCQt1ce-rnGlWMdSNntWvaeTiyWYxpgjOwTYN_V6n5x2FcobupkSu8HPwG4OIgJe2w1RkpPYJdav2P03oqztdusAjq9K5PCKfmp3taRTyi3mtOo4KJGenxdoO-PjU_0XLU0-I2UVFeyUJzP0WipCeCCGvzB6h6C66Z2JknLQq5H07R-67ERLoxSlWnl7VB-Hn6axlXIpU6APlIaEtDQrxFjF1Sq4CD7wJS1JIb0h38dHl2dtTNeF3Bi7b7d30JH6w4fclCOEEF0cBn5tWX7G9YQa8QAju3SLG2ucV3iG_ZxKJK-mX6SLcZH4T0yZi6WSGK5NGvTumsVM7jP2BaXqXEMMRFrn_yCq4WHfQ8hw==\" rel=\"nofollow\" target=\"_blank\">www.belitebio.com<\/a>.<\/p>\n<p>\n        <strong>Media and Investor Relations Contact:<\/strong><br \/>\n        <br \/>Jennifer Wu <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_2tFxkY7wHyQ1wNmkQEET57kEOZv3Axc10Qb5cvlkwzq2QAjDTYB-ktVSCWgpRttlK6KfdySIDxg6z-OFV-2jZtZULLkzTCTlpH33_YSiuM=\" rel=\"nofollow\" target=\"_blank\">ir@belitebio.com<\/a><\/p>\n<p>Julie Fallon<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZxOzrwi1AsUZ1BflSyh5GkOiYzFvqrTWQdkPzATNpILUq1I_l5rOVNKLy0f7D2LmswhCwd6fNueWVb7VAbqTuG2NLnwc_5DLvaLtpeZMPtuaDAPl2_QEMV-oxiWn0mVk\" rel=\"nofollow\" target=\"_blank\">belite@argotpartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWJhMDgxNGItY2MxMi00NTU3LTg1ZWQtM2RlM2Q2Zjc4ODdkLTEyNDUyODUtMjAyNS0wMy0xMS1lbg==\/tiny\/Belite-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, March 17, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the fourth quarter and full year ended December 31, 2024. Webcast Information Date: Monday, March 17, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https:\/\/events.q4inc.com\/attendee\/481614529 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-823958","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, March 17, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the fourth quarter and full year ended December 31, 2024. Webcast Information Date: Monday, March 17, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https:\/\/events.q4inc.com\/attendee\/481614529 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay &hellip; Continue reading &quot;Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-11T07:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results\",\"datePublished\":\"2025-03-11T07:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\"},\"wordCount\":280,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\",\"name\":\"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=\",\"datePublished\":\"2025-03-11T07:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk","og_description":"SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, March 17, 2025, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the fourth quarter and full year ended December 31, 2024. Webcast Information Date: Monday, March 17, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https:\/\/events.q4inc.com\/attendee\/481614529 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay &hellip; Continue reading \"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-11T07:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results","datePublished":"2025-03-11T07:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"},"wordCount":280,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","name":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=","datePublished":"2025-03-11T07:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjM2NCM2ODAwMjczIzIyMzM3MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-march-17-2025-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/823958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=823958"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/823958\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=823958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=823958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=823958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}